Last edition
News about "Lupin Limited"
Lupin Limited Receives USFDA EIR for Goa Manufacturing Facility
Lupin Limited has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration for its manufacturing facility in Goa. The report follows a recent inspection of the site and marks the formal closure of the regulatory review process.
Lupin Limited | 01/03/2026 | By Darshana
Lupin Limited partners with Spektus Pharma to commercialize DeslaFlex in Canada
Lupin Limited has signed a licence and supply agreement with Spektus Pharma to commercialize DeslaFlex, a novel antidepressant, in Canada.
Lupin Limited | 16/02/2026 | By Darshana
Lupin Launches Dasatinib Tablets in USA Following FDA Approval
Lupin Limited has announced the launch of dasatinib tablets in multiple strengths in the United States following approval of its Abbreviated New Drug Application from the USA Food and Drug Administration.
Lupin Limited | 03/02/2026 | By Darshana | 127
Lupin acquires brands ONDERO, ONDERO MET brand from Boehringer Ingelheim
Lupin acquires brands ONDERO, ONDERO MET brand from Boehringer Ingelheim
Lupin Limited | 21/08/2023 | By Sudeep Soparkar | 732
Lupins Mandideep Unit-2 Facility Completes U.S. FDA Inspection with No Observations
Lupin’s Mandideep Unit-2 Facility Completes U.S. FDA Inspection with No Observations
Lupin Limited | 14/08/2023 | By Sudeep Soparkar | 877
Lupin receives tentative approval from U.S. FDA for Dolutegravir Lamivudine and Tenofovir Alafenamide Tablets
Lupin Limited | 24/07/2023 | By Sudeep Soparkar | 632
Lupin Receives Approval from U.S. FDA for Chlorpromazine Hydrochloride Tablets USP
Lupin Receives Approval from U.S. FDA for Chlorpromazine Hydrochloride Tablets USP
Lupin Limited | 18/07/2023 | By Sudeep Soparkar | 617
Lupin receives approval from U.S. FDA for Diazepam Rectal Gel
Global pharma major Lupin Limited (Lupin) today announced that its wholly-owned subsidiary, Novel Laboratories Inc., based in Somerset, New Jersey, has received approval from the United States Food and Drug Administration (U.S. FDA)
Lupin Limited | 02/06/2023 | By Sudeep Soparkar | 768
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy